BIOMAT Database Logo BIOMAT Database Logo

Therapeutic strategies with monoclonal antibodies and immunoconjugates. 1988

V S Byers, and R W Baldwin
Cancer Research Campaign Laboratories, University of Nottingham, U.K.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000922 Immunotoxins Semisynthetic conjugates of various toxic molecules, including RADIOACTIVE ISOTOPES and bacterial or plant toxins, with specific immune substances such as IMMUNOGLOBULINS; MONOCLONAL ANTIBODIES; and ANTIGENS. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect. Affinotoxin,Antibody-Toxin Conjugate,Antibody-Toxin Conjugates,Antibody-Toxin Hybrid,Antibody-Toxin Hybrids,Chimeric Toxins,Cytotoxin-Antibody Conjugate,Cytotoxin-Antibody Conjugates,Monoclonal Antibody-Toxin Conjugate,Targeted Toxin,Targeted Toxins,Toxin Carriers,Toxin Conjugates,Toxin-Antibody Conjugate,Toxin-Antibody Conjugates,Toxin-Antibody Hybrid,Toxin-Antibody Hybrids,Toxins, Chimeric,Toxins, Targeted,Affinotoxins,Chimeric Toxin,Immunotoxin,Monoclonal Antibody-Toxin Conjugates,Toxin Carrier,Toxin Conjugate,Antibody Toxin Conjugate,Antibody Toxin Conjugates,Antibody Toxin Hybrid,Antibody Toxin Hybrids,Antibody-Toxin Conjugate, Monoclonal,Antibody-Toxin Conjugates, Monoclonal,Carrier, Toxin,Carriers, Toxin,Conjugate, Antibody-Toxin,Conjugate, Cytotoxin-Antibody,Conjugate, Monoclonal Antibody-Toxin,Conjugate, Toxin,Conjugate, Toxin-Antibody,Conjugates, Antibody-Toxin,Conjugates, Cytotoxin-Antibody,Conjugates, Monoclonal Antibody-Toxin,Conjugates, Toxin,Conjugates, Toxin-Antibody,Cytotoxin Antibody Conjugate,Cytotoxin Antibody Conjugates,Hybrid, Antibody-Toxin,Hybrid, Toxin-Antibody,Hybrids, Antibody-Toxin,Hybrids, Toxin-Antibody,Monoclonal Antibody Toxin Conjugate,Monoclonal Antibody Toxin Conjugates,Toxin Antibody Conjugate,Toxin Antibody Conjugates,Toxin Antibody Hybrid,Toxin Antibody Hybrids,Toxin, Chimeric,Toxin, Targeted

Related Publications

V S Byers, and R W Baldwin
Monoclonal antibodies, immunoconjugates, and liposomes as targeted therapeutic systems.
January 1990, Targeted diagnosis and therapy,
V S Byers, and R W Baldwin
Monoclonal antibodies and immunoconjugates in acute myeloid leukemia.
January 2006, Best practice & research. Clinical haematology,
V S Byers, and R W Baldwin
Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates.
January 2000, Cancer chemotherapy and pharmacology,
V S Byers, and R W Baldwin
Therapeutic monoclonal antibodies: strategies and challenges for biosimilars development.
January 2012, Current medicinal chemistry,
V S Byers, and R W Baldwin
Therapeutic strategies using monoclonal antibodies in autoimmune disease.
April 1989, Current opinion in immunology,
V S Byers, and R W Baldwin
Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
July 1998, The cancer journal from Scientific American,
V S Byers, and R W Baldwin
Monoclonal antibodies for the treatment of cancer: therapeutic strategies.
December 1989, Current opinion in oncology,
V S Byers, and R W Baldwin
Preparation and analysis of bifunctional immunoconjugates containing monoclonal antibodies OKT3 and BABR1.
January 1989, Cancer immunology, immunotherapy : CII,
V S Byers, and R W Baldwin
Pre-clinical strategies and safety issues in developing therapeutic monoclonal antibodies.
September 2011, New biotechnology,
V S Byers, and R W Baldwin
Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus.
March 2023, Drug discovery today,
Copied contents to your clipboard!